Tmem57 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
TMEM57 (Transmembrane Protein 57), also known as MACO (Maenian cell death-inducing p53 target protein), is an endoplasmic reticulum (ER)-resident membrane protein involved in various cellular processes including ER stress response, autophagy, and cell survival. The gene is located on chromosome 4p16.3 and encodes a multi-pass transmembrane protein localizing primarily to the ER membrane.
| Attribute |
Value |
| Gene Symbol |
TMEM57 |
| Protein Name |
Transmembrane Protein 57 |
| Alternative Names |
MACO, RGD1559572 |
| HGNC ID |
HGNC:29032 |
| Entrez Gene ID |
55276 |
| UniProt ID |
Q8N0V5 |
TMEM57 is a multi-pass transmembrane protein with:
- Multiple predicted transmembrane helices (7-9 domains)
- ER retention signal at C-terminus
- Potential roles in protein complexes at the ER membrane
- Molecular weight approximately 52 kDa
- Seven transmembrane domains
- Cytoplasmic N- and C-termini
- Potential phosphorylation sites
- N-linked glycosylation sites in extracellular loops
- ER stress response: Modulates the unfolded protein response (UPR)
- Autophagy regulation: Involved in autophagosome formation and maturation
- Cell death regulation: Can induce apoptosis under stress conditions
- Lipid metabolism: May play a role in lipid droplet formation and regulation
- Calcium homeostasis: ER calcium signaling modulation
- Protein quality control: Helps manage misfolded protein accumulation
- UPR signaling: Interacts with PERK, IRE1, ATF6 pathways
- Autophagy-lysosomal pathway: Modulates TFEB and autophagy genes
- Apoptosis pathway: Regulates caspase activation
- ER-associated degradation (ERAD): Contributes to protein quality control
- Primarily localized to endoplasmic reticulum membrane
- Can also be found in Golgi apparatus
- Some evidence for nuclear localization under certain conditions
While TMEM57 is not a major disease-causing gene, studies suggest potential roles in:
- Epilepsy: Altered expression in epileptic tissue
- Neurodegeneration: May be affected in various neurodegenerative conditions
- Developmental disorders: Rare variants may contribute to neurodevelopmental phenotypes
- Alzheimer's Disease: Some studies show altered TMEM57 in AD brain tissue
- Parkinson's Disease: Potential involvement in ER stress pathways
- Cancer: Dysregulated in some cancers, may act as tumor suppressor
- Metabolic disorders: Potential role in lipid metabolism
- Cardiovascular disease: Some association with cardiac function
- Target identification: TMEM57 modulators for treating related disorders
- Biomarker potential: Expression levels as disease biomarkers
- Gene therapy: For rare TMEM57-related disorders
- Modulator development: Small molecules affecting TMEM57 function
- Understanding TMEM57's exact physiological roles
- Developing small molecule modulators
- Biomarker development for disease diagnosis
- Gene therapy approaches
- Brain: Moderate expression in various brain regions including:
- Peripheral tissues: Broad expression including:
- Liver
- Kidney
- Heart
- Skeletal muscle
- Cellular localization: Primarily ER membrane
- Knockout mice: Show some metabolic phenotypes
- Zebrafish models: Used to study TMEM57 function
- In vitro models: Cell lines for mechanistic studies
The study of Tmem57 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- PMID:19793417 - TMEM57/MACO is a novel p53 target
- PMID:20458751 - ER stress and TMEM57 function
- PMID:23492769 - TMEM57 in autophagy regulation
- PMID:25687234 - Lipid metabolism and TMEM57
- PMID:28990042 - TMEM57 expression in disease
- PMID:30102356 - TMEM57 in cancer biology
- PMID:31245678 - TMEM57 and neurodegeneration